10 February 2022: Clinical Research
A Single-Center, Randomized, Double-Blind Study of 94 Patients Undergoing Surgery for Cerebral Glioma to Compare Postoperative Thromboprophylaxis with and without Rivaroxaban
Zi-Yan Wang 1ABC , You-Dong Wan 2CDEF , Xian-Zhi Liu 1EFG , Hao Wang 1AD , Guang-Yi Jiang 1ABF , Bo Yang 1ABCDEFG*DOI: 10.12659/MSM.934341
Med Sci Monit 2022; 28:e934341
Figure 2 Comparison of incidence of VTE between rivaroxaban and placebo groups.